[go: up one dir, main page]

CN109224216A - Physiotherapy equipment for respiratory system - Google Patents

Physiotherapy equipment for respiratory system Download PDF

Info

Publication number
CN109224216A
CN109224216A CN201811234347.7A CN201811234347A CN109224216A CN 109224216 A CN109224216 A CN 109224216A CN 201811234347 A CN201811234347 A CN 201811234347A CN 109224216 A CN109224216 A CN 109224216A
Authority
CN
China
Prior art keywords
drug
opening
shell
main pipeline
cover
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811234347.7A
Other languages
Chinese (zh)
Other versions
CN109224216B (en
Inventor
扣璇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JINAN CHILDREN'S HOSPITAL
Original Assignee
Hangzhou Guang Kai Medical Science And Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Guang Kai Medical Science And Technology Development Co Ltd filed Critical Hangzhou Guang Kai Medical Science And Technology Development Co Ltd
Priority to CN201811234347.7A priority Critical patent/CN109224216B/en
Publication of CN109224216A publication Critical patent/CN109224216A/en
Application granted granted Critical
Publication of CN109224216B publication Critical patent/CN109224216B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1025Respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The invention discloses a kind of physiotherapy equipments for respiratory system, comprising: drug effect component and drug supply part;Drug effect component includes: cover;First shell is formed with main pipeline, admission line and outlet pipe in first shell;Main pipeline penetrates through cover;Admission line main conduit extends to cover;Outlet pipe main conduit extends to outside first shell;The junction of admission line and main pipeline forms the first opening, the second opening of junction formation of outlet pipe and main pipeline;Valve member, its opening and closing for being used to control the first opening and the second opening, when patient carries out air-breathing, valve member opens the first opening, and the second opening is closed, so that drug passes through main pipeline, admission line and cover, and when patient exhales, valve member opens the second opening, and closes the first opening, and patient exhalation air is discharged outside first shell by cover, main pipeline and outlet pipe.

Description

Physiotherapy equipment for respiratory system
Technical field
The present invention relates to the field of medical instrument technology, in particular to a kind of physiotherapy equipment for respiratory system.
Background technique
Patient with respiratory tract system disease, it is sometimes desirable to make the therapeutic scheme for taking tablet and draw the treatment of drug Scheme carries out (so that drug is directly arrived at affected area has quick direct effect for treatment) simultaneously, in the prior art, to patient It carries out directly absorption drug therapy to need using drug supply arrangement, drug supply generally includes a cover and a drug Supply part, for cover for be located in patient facial region, drug supply part is connected to cover, drug supply unit by a hose Part generally includes a container, and drug is accommodated in the container and drug is extracted and passed through by a draw-off pump, the draw-off pump Drug is conveyed to cover with certain pressure by hose.
Said medicine supply arrangement in the prior art has following defects that
Well known, patient has when carrying out the respiration period there are two process, first is that breathing process, second is that exhaling Journey is inhaled by a patient in breathing process into the intracorporal gas of cover (drug);Gas is not and in exhalation process, in cover Patient's body can be entered.
Since no matter above-mentioned drug supply arrangement is in patient breaths or when exhaling, drug is entered always with certain pressure In cover, and as the patient exhales, entering the intracorporal drug of cover via hose will not be utilized, which can breathe out with patient Gas between cover and face gap outflow, thus it is possible, on the one hand, drug flow into external environment, external environment is caused Pollution;On the other hand, drug flows into the waste that external environment causes drug;In another aspect, when gap is smaller, patient expiration's mistake Journey can be obstructed, the feeling felt suffocated to patient.
Summary of the invention
For the above-mentioned technical problems in the prior art, the embodiment provides one kind to be used for respiratory system Physiotherapy equipment.
In order to solve the above technical problems, the embodiment of the present invention the technical solution adopted is that:
A kind of physiotherapy equipment for respiratory system, comprising: drug effect component and drug supply part;
The drug effect component includes
Cover is used to cover at the face of patient;
First shell, the cover are connected to the proximal end of the first shell, be formed in the first shell main pipeline, Admission line and outlet pipe;The main pipeline extends from the distal end of the first shell towards proximal end and penetrates through the cover; The admission line extends to the cover from the main pipeline;The outlet pipe extends to described first from the main pipeline Outside shell;The junction of the admission line and the main pipeline forms the first opening, the outlet pipe and the main pipeline Junction formed second opening;The drug supply part is connected to the distal end of the first shell and connects with the main pipeline It passes to the main pipeline and drug is provided;
Valve member is used to control the opening and closing of first opening and second opening, to carry out air-breathing as the patient When, the valve member opens first opening, and second opening is closed, so that drug passes through the supervisor Road, admission line and cover, and when the patient exhales, the valve member opens second opening, and makes First opening is closed, and patient exhalation air is discharged outside the first shell by cover, main pipeline and outlet pipe.
Preferably, the main pipeline has one section of linearly extended drug control section, first opening and described second Opening is located in the drug control section, and the main pipeline penetrates through the middle part of the cover;Wherein:
The valve member is set in the drug control section and can control along the drug control section, and with the drug Section sealing cooperation;
First opening is open close to the distal end of the first shell compared to described second, with when the patient inhales, The main pipeline between the valve member and the proximal end forms negative pressure and the valve member is made to close institute towards the proximal slide It states the second opening and simultaneously opens first opening, and as the patient expiration, between the valve member and the proximal end Main pipeline in pressure increase and slide the valve member distally and make the second opening open and close described first Opening.
Preferably, it is provided with the first filter element in the outlet pipe, with when patient exhales, first mistake It filters outside the drug outflow first shell of outlet pipe described in component entry deterrence.
Preferably, cavity is formed in the cover, the admission line is connected to the lateral surface that the cover deviates from patient And be connected to the cavity, the medial surface of the cover towards patient offer the through-hole of multiple perforation cavitys.
Preferably, the smallest cross-sectional of the main pipeline is greater than the smallest cross-sectional of the admission line.
Preferably, the drug supply part includes:
Second shell has a first end and a second end, and the first end of the second shell is connected to the first shell Distal end;
Body is limited, is set in the second shell, the inner wall of the outer peripheral surface for limiting body and the second shell Runner is limited, first end is flowed to enter the main pipeline with the second end for enabling air to from second shell;The restriction It is also formed with supply unit in vivo, the restriction body offers feed path, the supply unit towards the supply unit from its periphery Drug is provided to the runner by the feed path.
Preferably, the supply unit includes:
Column chamber is opened on the restriction body, and the column is intracavitary to be accommodated with drug, the feed path with it is described The perforation of column chamber;
Piston is set to the column chamber and can slide along the column chamber;
Component is pre-tightened, is used to that the piston to be enable to oppress the intracavitary drug of the column with certain thrust as drug It flows into the runner and power is provided.
Preferably, the supply channel is vertically through the outer peripheral surface for limiting body.
Preferably, it is described limit body outer peripheral surface and with it is described limit body periphery towards in corresponding second shell Wall is tapered surface;Wherein:
The restriction body is set to change the cross-sectional sizes of the runner along the axis direction sliding of the tapered surface.
Preferably, it is provided with the second filter element in the runner, to be filtered to the air entered in the runner.
Compared with prior art, the beneficial effect of the physiotherapy equipment disclosed by the invention for respiratory system is: when patient into When row is exhaled, valve member opens the second opening, and closes the first opening.The gas of patient's exhalation passes through cover, main pipeline And outside outlet pipe discharge first shell, so that the gas of patient expiration will not be flowed into outside by the gap of cover and face In boundary's environment, feel suffocated so as to prevent patient from generating when exhaling.
Detailed description of the invention
Fig. 1 is that for the structural schematic diagram of the physiotherapy equipment of respiratory system, (patient is carried out provided by the embodiment of the present invention State when air-breathing).
Fig. 2 is the enlarged view of the local A of Fig. 1.
Fig. 3 is the enlarged view of the local B of Fig. 1.
Fig. 4 is that for the structural schematic diagram of the physiotherapy equipment of respiratory system, (patient is carried out provided by the embodiment of the present invention State when expiration).
Fig. 5 is the enlarged view of the Local C of Fig. 4.
Fig. 6 is the structure provided by the embodiment of the present invention for the drug supply part in the physiotherapy equipment of respiratory system Schematic diagram (sectional dimension of runner is H1).
Fig. 7 is the structure provided by the embodiment of the present invention for the drug supply part in the physiotherapy equipment of respiratory system Schematic diagram (sectional dimension of runner is H2).
In figure:
100- face;10- drug effect component;11- first shell;111- main pipeline;1111- drug control section;112- Admission line;1121- first is open;113- outlet pipe;1131- second is open;The first filter element of 1132-;12- cover; 121- cavity;122- through-hole;13- valve member;20- drug supply part;21- second shell;22- limits body;221- feed path; 23- runner;24- supply unit;241- column chamber;242- piston;243- spring;The top 244- is female;245- check valve;The second mistake of 25- Filter component.
Specific embodiment
Technical solution in order to enable those skilled in the art to better understand the present invention, with reference to the accompanying drawing and specific embodiment party Formula elaborates to the present invention.
As shown in Fig. 1 to 7, the embodiment of the present invention discloses a kind of physiotherapy equipment for respiratory system, which is used for The respiratory disease of patient is treated, for example, pneumonia or bronchial asthma can be treated.Patient is sucked drug by the physiotherapy equipment Intracorporal affected area is to obtain quick therapeutic effect.The physiotherapy equipment includes drug effect component 10 and drug supply part 20, Drug supply part 20 is used to provide drug (drug of atomization) for drug effect component 10, and drug effect component 10 is for making to suffer from Person sucks the drug and can at least guarantee that patient expiration's movement is smooth.
Specifically, drug effect component 10 includes cover 12, first shell 11 and valve member 13.First shell 11 has close End and distal end (proximal end, which refers to, distally refers to one end far from patient facial region 100 close to one end of patient facial region 100), cover 12 It is connected to the proximal end of first shell 11, the cover 12 is for be located in its glasses face below when patient is using physiotherapy equipment 100, that is, nose and mouth can be coated.Main pipeline 111, admission line 112 and outlet pipe are formed in first shell 11 113, wherein main pipeline 111 extends from the distal end of first shell 11 towards proximal end and penetrates through cover 12;Admission line 112 is responsible for certainly Road 111 extends to cover 12;113 main conduit 111 of outlet pipe extends to outside first shell 11;Admission line 112 and supervisor The junction in road 111 forms the first opening 1121, the second opening 1131 of junction formation of outlet pipe 113 and main pipeline 111; Drug supply part 20 is connected to the distal end of first shell 11 and is connected to main pipeline 111 to provide drug to main pipeline 111.Valve Part 13 is configured as the opening and closing of control the first opening 1121 and the second opening 1131 during patient exhales, inhales.Specific controlling party Formula are as follows: as shown in Figure 1, valve member 13 opens the first opening 1121, and makes the second opening 1131 when patient carries out air-breathing It closes, thus it is possible, on the one hand, to form an access between drug supply part 20 and human body, so as to pass through drug Main pipeline 111, admission line 112 and cover 12 enter human body;On the other hand, the aspiratory action of patient makes admission line Negative pressure is formed in 112, under the action of negative pressure, drug main conduit 111 is automatically into air inlet provided by drug supply part 20 Pipeline 112, and be inhaled into the respiratory system of human body through admission line 112 and by cover 12, from without drug is supplied Component 20 is provided to the component with the drug of certain pressure, and (drug supply part 20 in the prior art is to have drug There is certain pressure and draw-off pump is set, so that whole equipment improves cost, and drug can not be stopped when patient exhales Supply).As shown in figure 4, valve member 13 opens the second opening 1131, and makes the first opening when patient exhales 1121 close.First shell 11 is discharged by cover 12, main pipeline 111 and outlet pipe 113 in the gas of patient's exhalation in this way It (flows into external environment) outside, so that the gas of patient expiration will not flow into the external world by the gap of cover 12 and face 100 In environment, (patient can be provided by increasing the section of outlet pipe 113 so as to prevent patient from generating to feel suffocated when exhaling The smoothness of expiration).
Above-mentioned valve member 13 is controlled to act, in a manner of making the opening and closings of two openings of control in real time of valve member 13 there are many, example Such as, it can be acted by outer force control valve part 13, e.g., valve member 13 be controlled by electric signal and is acted.It is preferred real at of the invention one It applies in example, as shown in Figure 1 and Figure 4, controls the pressure influence in main pipeline 111 valve member 13 using the respiratory movement of patient One section of linearly extended drug control section 1111, the both ends of the drug control section 1111 are arranged in movement, specifically, main pipeline 111 It is formed with ladder, and the first opening 1121 and the second opening 1131 are located in drug control section 1111, main pipeline 111 penetrates through cover 12 middle part;Valve member 13 is set in drug control section 1111 and can slide along drug control section 1111, and controls with drug 1111 sealing cooperation of section;First opening 1121, close to the distal end of first shell 11, is inhaled compared to the second opening 1131 with working as patient When gas, as shown in Figure 1, the main pipeline 111 between valve member 13 and proximal end forms negative pressure and closes valve member 13 towards proximal slide Second opening 1131 simultaneously opens the first opening 1121 simultaneously, and as the patient exhales, the main pipeline between valve member 13 and proximal end Pressure in 111 increases and slides valve member 13 distally and open the second opening 1131 and close the first opening 1121.In the present embodiment, it is acted using patient respiratory to the pressure generation in the main pipeline 111 between valve member 13 and proximal end It influences to control valve member 13 and act, so that patient be enable to open admission line 112 in air-breathing, can be used in breathing Feed channel 113 is opened.Keep the movement of valve member 13 consistent with respiratory movement, and without in external force.
In a preferred embodiment of the invention, outlet pipe 113 includes a plurality of, the circumferential cloth of a plurality of outlet pipe 113 It sets, such as Fig. 5 and as shown in connection with fig. 4, first filter element 1132 is set far from one end of main pipeline 111 in outlet pipe 113, such as This, when patient exhales, into outlet pipe 113 the gas breathed out after the filtering of the first filter element 1132 It is discharged outside first shell 11, which is configured to contained drug discharge in prevention gas, and (drug is if particle Shape, can the first filter element 1132 be arranged to the film for only allowing gas to pass through).In the present embodiment, pass through the first filtering of setting Component 1132 drug can be prevented to be discharged into external environment, so as to avoid to external environment when patient exhales It pollutes.
In a preferred embodiment of the invention, such as Fig. 2 and as shown in connection with fig. 1, cavity 121 is formed in cover 12, into Feed channel 112 is connected to cover 12 away from the lateral surface of patient and is connected to cavity 121, and the medial surface of cover 12 towards patient are opened Through-hole 122 equipped with multiple Through-cavities 121.In the present embodiment, mixed in admission line 112 when patient carries out air-breathing There is the gas of drug to enter in cavity 121, then, is flowed out by through-hole 122 and be inhaled by a patient again outside cover 12, in this way, cavity 121 pairs of drugs have certain storage effect, and when the aspiratory action of patient is uneven, cavity 121 is to the Sucked medicine of patient Measurer has certain buffer function, so that the soakage of drug increases with the suction of patient and increased, reduces and reduces, to drop as far as possible It is influenced caused by the insufficient movement to patient breaths of the drug supply amount of low admission line 112.
For the sensitivity of the movement of raising valve member 13, the smallest cross-sectional of main pipeline 111 is made to be greater than the minimum of admission line 112 Section.In this way, gas increases faster, to make valve the pushing force of valve member 13 in main pipeline 111 when patient exhales The movement of part 13 is sensitiveer.
In a preferred embodiment of the invention, drug supply part 20 includes: second shell 21 and restriction body 22. Second shell 21 has a first end and a second end, and the first end of second shell 21 is connected to the distal end of first shell 11;Limit body 22 are set in second shell 21, and the inner wall of the outer peripheral surface and second shell 21 that limit body 22 limits runner 23, so that air Can be flowed to from the second end of second shell 21 first end with enter main pipeline 111, it is preferable that limit body 22 outer peripheral surface and It towards the inner wall of corresponding second shell 21 is tapered surface with the periphery for limiting body 22;Wherein: enabling to limit body 22 along cone The axis direction sliding in shape face is to change the cross-sectional sizes of runner 23 (for example, as shown in fig. 7, making to limit body 22 towards second shell 21 the first extreme direction is mobile and fixed, to obtain the sectional dimension H2 of smaller runner 23;As shown in fig. 6, making to limit body 22 towards second shell 21 the second extreme direction it is mobile and fixed, to obtain the sectional dimension H1 of smaller runner 23).Limit body It is also formed with supply unit 24 in 22, limits body 22 from its periphery and offers feed path 221 towards supply unit 24, supply unit 24 is logical It crosses feed path 221 and provides drug to runner 23.Specifically, supply unit 24 includes: column chamber 241, piston 242 and preload group Part.Column chamber 241, which is opened in, to be limited on body 22, drug is accommodated in column chamber 241, feed path 221 is passed through with column chamber 241 It is logical, it is preferable that supply channel 23 is vertically through the outer peripheral surface for limiting body 22.Piston 242 is set to column chamber 241 and can be along column Shape chamber 241 slides.One top mother 244 of component packet and spring 243 are pre-tightened, on limiting body 22, spring 243 is set 244 setting of top mother It is placed between top mother 244 and piston 242, which has certain pushing and pressing effect to piston 242, so that piston 242 is with one The drug determined in thrust compressing column chamber 241 provides power can flow into runner 23 for drug.In a preferred embodiment, top Mother 244 can change the compression degree of spring 243 by rotating.In a preferred embodiment, as shown in figure 3, being leaned in runner 23 Second filter element 25 is set on the position of the second end of nearly second shell 21, second filter element 25 is for preventing in air Dust enter in runner 23, and then sucked after entry deterrence drug effect component 10 by human body.In a preferred embodiment, Check valve 245 is set on piston 242, adds drug into column chamber 241 to facilitate.
The advantage of above-described embodiment is:
1, drug effect component 10 provided by above-described embodiment is not used to actively continue to mention to drug effect component 10 For drug, which provides drug to drug effect component 10 according to the respiratory movement of patient.For example, working as patient When carrying out air-breathing, negative pressure is formed in admission line 112, outside air enters runner 23 from the second end of second shell 21, enters The gas of runner 23, which generates impact to the drug flowed into runner 23 by feed path 221 with certain flow velocity, makes its atomization, To making the drug through being atomized flow through main pipeline 111, admission line 112, cover 12 and suck human body;And when patient's air inlet is exhaled When, admission line 112 is blocked by valve member 13, suction function is not present, therefore, outside air will not enter runner 23.Therefore, on Drug effect component 10 provided by embodiment is stated only when patient carries out air-breathing, just can be that drug effect component 10 and patient mention It (is only acted herein, patient just needs Sucked medicine) for drug, and when exhaling, drug is not provided for it (act, suffer from herein Person does not need drug), so as to prevent drug waste.
2, it in above-mentioned preferred embodiment, limits body 22 and is able to carry out position adjusting, so as to improve drug concentration, example Such as, as shown in fig. 7, passing through the stream of the gas of runner 23 when limiting body 22 by moving so that the cross section of runner 23 becomes smaller Speed increases, this certainly will increase gas to the atomizing of drug, so that the drug being mixed in gas increases, conversely, in gas The drug that is mixed with reduce.
3, in above-mentioned preferred embodiment, make feed path 221 vertically through outer peripheral surface, to allow gas to enough vertically rush Drug is hit, and then improves the nebulization efficiency of drug.
4, in an above-mentioned preferred embodiment, the compression degree of spring 243 is adjusted by rotation top mother 244, thus Piston 242 is adjusted to the level of compression of drug, and then adjusts the amount that drug flows into runner 23.
Above embodiments are only exemplary embodiment of the present invention, are not used in the limitation present invention, protection scope of the present invention It is defined by the claims.Those skilled in the art can within the spirit and scope of the present invention make respectively the present invention Kind modification or equivalent replacement, this modification or equivalent replacement also should be regarded as being within the scope of the present invention.

Claims (10)

1. a kind of physiotherapy equipment for respiratory system characterized by comprising drug effect component and drug supply part;
The drug effect component includes:
Cover is used to cover at the face of patient;
First shell, the cover are connected to the proximal end of the first shell, main pipeline, air inlet are formed in the first shell Pipeline and outlet pipe;The main pipeline extends from the distal end of the first shell towards proximal end and penetrates through the cover;It is described Admission line extends to the cover from the main pipeline;The outlet pipe extends to the first shell from the main pipeline Outside;The junction of the admission line and the main pipeline forms the first opening, the company of the outlet pipe and the main pipeline It meets place and forms the second opening;The drug supply part be connected to the distal end of the first shell and be connected to the main pipeline with Drug is provided to the main pipeline;
Valve member, be used to control it is described first opening and it is described second opening opening and closing, with when the patient carry out air-breathing when, institute Stating valve member opens first opening, and second opening is closed, so that drug passes through the main pipeline, air inlet Pipeline and cover, and when the patient exhales, the valve member opens second opening, and makes described first Opening is closed, and patient exhalation air is discharged outside the first shell by cover, main pipeline and outlet pipe.
2. the physiotherapy equipment according to claim 1 for respiratory system, which is characterized in that the main pipeline is straight with one section The drug control section that line extends, first opening and second opening are located in the drug control section, the main pipeline Penetrate through the middle part of the cover;Wherein:
The valve member is set in the drug control section and can be and close with the drug control section along the drug control section Envelope cooperation;
First opening is open close to the distal end of the first shell compared to described second, described with when the patient inhales The main pipeline between valve member and the proximal end forms negative pressure and the valve member is made to close described the towards the proximal slide Two openings simultaneously simultaneously open first opening, and the master as the patient expiration, between the valve member and the proximal end Pressure in pipeline increases and slides the valve member distally and open the second opening and close first opening.
3. the physiotherapy equipment according to claim 1 for respiratory system, which is characterized in that be provided in the outlet pipe First filter element, with when patient exhales, the drug stream of outlet pipe described in the first filter element entry deterrence Out outside first shell.
4. the physiotherapy equipment according to claim 1 for respiratory system, which is characterized in that cavity is formed in the cover, The admission line is connected to the cover away from the lateral surface of patient and is connected to the cavity, and the cover is towards patient's Medial surface offers the through-hole of multiple perforation cavitys.
5. the physiotherapy equipment according to claim 2 for respiratory system, which is characterized in that the smallest cross-sectional of the main pipeline Greater than the smallest cross-sectional of the admission line.
6. the physiotherapy equipment according to claim 1 for respiratory system, which is characterized in that the drug supply part packet It includes:
Second shell has a first end and a second end, and the first end of the second shell is connected to the remote of the first shell End;
Body is limited, is set in the second shell, the inner wall of the outer peripheral surface for limiting body and the second shell limits Runner out flows to first end with the second end for enabling air to from second shell to enter the main pipeline;It is described to limit in vivo It is also formed with supply unit, the restriction body offers feed path towards the supply unit from its periphery, and the supply unit passes through The feed path provides drug to the runner.
7. the physiotherapy equipment according to claim 6 for respiratory system, which is characterized in that the supply unit includes:
Column chamber is opened on the restriction body, and the column is intracavitary to be accommodated with drug, the feed path and the column Chamber perforation;
Piston is set to the column chamber and can slide along the column chamber;
Component is pre-tightened, is used to that the piston to be enable to oppress the intracavitary drug of the column with certain thrust to flow into for drug The runner provides power.
8. the physiotherapy equipment according to claim 6 for respiratory system, which is characterized in that the supply channel vertically through The outer peripheral surface for limiting body.
9. the physiotherapy equipment according to claim 6 for respiratory system, which is characterized in that it is described limit body outer peripheral surface with It and with the periphery for limiting body towards the inner wall of corresponding second shell is tapered surface;Wherein:
The restriction body is set to change the cross-sectional sizes of the runner along the axis direction sliding of the tapered surface.
10. the physiotherapy equipment according to claim 6 for respiratory system, which is characterized in that be provided in the runner Two filter elements, to be filtered to the air entered in the runner.
CN201811234347.7A 2018-10-23 2018-10-23 Physiotherapy equipment for respiratory system Expired - Fee Related CN109224216B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811234347.7A CN109224216B (en) 2018-10-23 2018-10-23 Physiotherapy equipment for respiratory system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811234347.7A CN109224216B (en) 2018-10-23 2018-10-23 Physiotherapy equipment for respiratory system

Publications (2)

Publication Number Publication Date
CN109224216A true CN109224216A (en) 2019-01-18
CN109224216B CN109224216B (en) 2021-04-13

Family

ID=65081249

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811234347.7A Expired - Fee Related CN109224216B (en) 2018-10-23 2018-10-23 Physiotherapy equipment for respiratory system

Country Status (1)

Country Link
CN (1) CN109224216B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111589064A (en) * 2020-05-25 2020-08-28 吉林大学 A kind of lung exhalation training device for patient care in cardiothoracic surgery

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2317878Y (en) * 1997-09-22 1999-05-12 吴修荣 Mask of oxygenating atomizing inhaler
CN1365294A (en) * 1999-06-30 2002-08-21 吸入治疗系统公司 Systems and methods for aerosolizing pharmaceutical formulations
CN203647823U (en) * 2014-01-06 2014-06-18 王江涛 Drug delivery device for pneumology department
US20150122248A1 (en) * 2013-11-04 2015-05-07 Stamford Devices Limited Aerosol delivery system
CN205729927U (en) * 2016-01-11 2016-11-30 西华大学 Full-automatic breathing self adaptation medical vaporizer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2317878Y (en) * 1997-09-22 1999-05-12 吴修荣 Mask of oxygenating atomizing inhaler
CN1365294A (en) * 1999-06-30 2002-08-21 吸入治疗系统公司 Systems and methods for aerosolizing pharmaceutical formulations
US20150122248A1 (en) * 2013-11-04 2015-05-07 Stamford Devices Limited Aerosol delivery system
CN203647823U (en) * 2014-01-06 2014-06-18 王江涛 Drug delivery device for pneumology department
CN205729927U (en) * 2016-01-11 2016-11-30 西华大学 Full-automatic breathing self adaptation medical vaporizer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111589064A (en) * 2020-05-25 2020-08-28 吉林大学 A kind of lung exhalation training device for patient care in cardiothoracic surgery
CN111589064B (en) * 2020-05-25 2021-01-29 吉林大学 Lung expiration training device for nursing cardiothoracic surgery patient

Also Published As

Publication number Publication date
CN109224216B (en) 2021-04-13

Similar Documents

Publication Publication Date Title
JP5253452B2 (en) Nasal infeed device
RU2432190C2 (en) Jet control inhaler based on inlet velocity and related methods of using
AU2004210560B2 (en) Continuous High-Frequency Oscillation Breathing Treatment Apparatus
US6230703B1 (en) Aerosol inhalation device providing improved aerosol delivery
CN105833403B (en) A kind of lung ventilator that can automatically adjust respiratory rate
CN110404145B (en) Oxygen therapy device with accurately adjustable inhaled oxygen concentration and without carbon dioxide retention
CN104870038A (en) Nebulizer with integrated breathing incentive
CN106820345A (en) A kind of safety goggles haze mouth mask
EP3810240A1 (en) Respiratory therapy devices and assemblies
CN115040732A (en) A atomizing device for children's respiratory track treatment
CN208340024U (en) A kind of novel Respiratory Medicine lung capacity training device
JP2019520925A (en) Application of powder aerosol to respiratory control during artificial respiration or respiratory assistance of a patient
CN208989964U (en) A kind of medical oxygen mask
CN108472457A (en) Air flowing in atomizer head
CN113058119A (en) Atomizer capable of preventing liquid medicine from being wasted and facilitating absorption
CN209270529U (en) Nebulized breathing device for respiratory department
CN109224216A (en) Physiotherapy equipment for respiratory system
JP2024527178A (en) Drug aerosol delivery device for artificial respirators
CN206715012U (en) A kind of vaporizer
CN112827042A (en) An oxygen delivery mask suitable for the treatment of lung diseases
CN111450364A (en) Mist control suction device
CN207614149U (en) Atomizing inhalation device for paediatric internal medicine
TWI738506B (en) Respiratory assist device
CN100548402C (en) Inhalation type drug delivery device
CN208809240U (en) A kind of medicine atomizer for saving dose

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Liu Xia

Inventor after: Kong Dexiao

Inventor after: Li Changxiao

Inventor after: Kun Xuan

Inventor before: Kun Xuan

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20210322

Address after: 250022 No. 23976, No. ten road, Huaiyin District, Ji'nan, Shandong

Applicant after: Jinan Children's Hospital

Address before: Room 101-5, building 5, shengaoming building, Wuchang Street, Yuhang District, Hangzhou City, Zhejiang Province

Applicant before: HANGZHOU GUANGQI MEDICAL TECHNOLOGY DEVELOPMENT Co.,Ltd.

GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210413

Termination date: 20211023